Literature DB >> 28990454

Perceived risks and use of psychotherapy via telemedicine for patients at risk for suicide.

Amanda K Gilmore1, Erin F Ward-Ciesielski2.   

Abstract

INTRODUCTION: Suicide is a major public health problem and its human, emotional, and economic costs are significant. Individuals in rural areas are at highest risk for suicide. However, telemedicine services are typically not rendered to individuals who are actively suicidal. The goals of the current study were to identify the risks of using telemedicine for mental healthcare from the perspective of licensed mental health providers and to determine factors associated with the use of telemedicine with patients who are at high risk for suicide.
METHODS: A total of 52 licensed mental health providers were recruited online through several professional organization listservs and targeted emails. Providers completed online questionnaires regarding demographics, caseload of suicidal patients, perceived risks for using telemedicine with patients at risk for suicide, attitudes towards telemedicine, and use of telemedicine with patients at risk for suicide.
RESULTS: Three key perceived risks associated with using telemedicine were identified, including assessment, lack of control over patient, and difficulties triaging patients if needed. It was also found that individuals who had more positive attitudes towards telemedicine, younger providers, and more experienced providers were more likely to use telemedicine with patients who are at high risk for suicide. DISCUSSION: To our knowledge, this is the first study to examine the perceived risks and use of telemedicine with patients at high risk for suicide. It is essential to continue this line of research to develop protocols for the provision of evidence-based therapy via telemedicine for this high-risk group.

Entities:  

Keywords:  Telemedicine; provider attitudes; suicide

Mesh:

Year:  2017        PMID: 28990454      PMCID: PMC5940577          DOI: 10.1177/1357633X17735559

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  15 in total

Review 1.  Contact with mental health and primary care providers before suicide: a review of the evidence.

Authors:  Jason B Luoma; Catherine E Martin; Jane L Pearson
Journal:  Am J Psychiatry       Date:  2002-06       Impact factor: 18.112

2.  VA community mental health service providers' utilization of and attitudes toward telemental health care: the gatekeeper's perspective.

Authors:  John Paul Jameson; Mary Sue Farmer; Katharine J Head; John Fortney; Cayla R Teal
Journal:  J Rural Health       Date:  2011-03-01       Impact factor: 4.333

3.  Practice guidelines for videoconferencing-based telemental health - October 2009.

Authors:  Peter Yellowlees; Jay Shore; Lisa Roberts
Journal:  Telemed J E Health       Date:  2010-12       Impact factor: 3.536

Review 4.  Technology-based suicide prevention: current applications and future directions.

Authors:  David D Luxton; Jennifer D June; Julie T Kinn
Journal:  Telemed J E Health       Date:  2011-01-09       Impact factor: 3.536

5.  Guidelines for the practice of telepsychology.

Authors: 
Journal:  Am Psychol       Date:  2013-12

6.  Managing suicidality in home-based telehealth.

Authors:  Daniel F Gros; Kimberly Veronee; Martha Strachan; Kenneth J Ruggiero; Ron Acierno
Journal:  J Telemed Telecare       Date:  2011-08-15       Impact factor: 6.184

7.  Health care contacts in the year before suicide death.

Authors:  Brian K Ahmedani; Gregory E Simon; Christine Stewart; Arne Beck; Beth E Waitzfelder; Rebecca Rossom; Frances Lynch; Ashli Owen-Smith; Enid M Hunkeler; Ursula Whiteside; Belinda H Operskalski; M Justin Coffey; Leif I Solberg
Journal:  J Gen Intern Med       Date:  2014-02-25       Impact factor: 5.128

8.  Effect of mobile phone-based psychotherapy in suicide prevention: a randomized controlled trial in Sri Lanka.

Authors:  Rohana B Marasinghe; Sisira Edirippulige; David Kavanagh; Anthony Smith; Mohamad T M Jiffry
Journal:  J Telemed Telecare       Date:  2012-02-23       Impact factor: 6.184

9.  Urban and rural utilization of evidence-based practices for substance use and mental health disorders.

Authors:  Jo Ann Walsh Dotson; John M Roll; Robert R Packer; Jennifer M Lewis; Sterling McPherson; Donelle Howell
Journal:  J Rural Health       Date:  2014-04-06       Impact factor: 4.333

Review 10.  VA telemental health: suicide assessment.

Authors:  Linda Godleski; J Edwin Nieves; Adam Darkins; Laurent Lehmann
Journal:  Behav Sci Law       Date:  2008
View more
  20 in total

Review 1.  Use of Telepsychiatry in Emergency and Crisis Intervention: Current Evidence.

Authors:  Isabelle Reinhardt; Euphrosyne Gouzoulis-Mayfrank; Jürgen Zielasek
Journal:  Curr Psychiatry Rep       Date:  2019-07-01       Impact factor: 5.285

2.  Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic.

Authors:  Danuta Wasserman; Miriam Iosue; Anika Wuestefeld; Vladimir Carli
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

3.  Synchronous Telehealth Yoga and Cognitive Processing Group Therapies for Women Veterans with Posttraumatic Stress Disorder: A Multisite Randomized Controlled Trial Adapted for COVID-19.

Authors:  Belle Zaccari; Jennifer M Loftis; Terri Haywood; Kimberly Hubbard; Jennifer Clark; Ursula Ann Kelly
Journal:  Telemed J E Health       Date:  2022-03-29       Impact factor: 5.033

4.  Factors influencing uptake of telemental health via videoconferencing at high and low adoption sites within the Department of Veterans Affairs during COVID-19: a qualitative study.

Authors:  Samantha L Connolly; Jennifer L Sullivan; Jan A Lindsay; Stephanie L Shimada; Leonie Heyworth; Kendra R Weaver; Christopher J Miller
Journal:  Implement Sci Commun       Date:  2022-06-20

5.  Telepsychotherapy with Youth at Clinical High Risk for Psychosis: Clinical Issues and Best Practices during the COVID-19 Pandemic.

Authors:  Joseph S DeLuca; Nicole D Andorko; Doha Chibani; Samantha Y Jay; Pamela J Rakhshan Rouhakhtar; Emily Petti; Mallory J Klaunig; Elizabeth C Thompson; Zachary B Millman; Kathleen M Connors; LeeAnn Akouri-Shan; John Fitzgerald; Samantha L Redman; Caroline Roemer; Miranda A Bridgwater; Jordan E DeVylder; Cheryl A King; Steven C Pitts; Shauna P Reinblatt; Heidi J Wehring; Kristin L Bussell; Natalee Solomon; Sarah M Edwards; Gloria M Reeves; Robert W Buchanan; Jason Schiffman
Journal:  J Psychother Integr       Date:  2020-06

6.  Clinicians' Perceptions of Rapid Scale-up of Telehealth Services in Outpatient Mental Health Treatment.

Authors:  Dawn E Sugarman; Lisa E Horvitz; Shelly F Greenfield; Alisa B Busch
Journal:  Telemed J E Health       Date:  2021-02-18       Impact factor: 3.536

7.  Patient and provider predictors of telemental health use prior to and during the COVID-19 pandemic within the Department of Veterans Affairs.

Authors:  Samantha L Connolly; Kelly L Stolzmann; Leonie Heyworth; Jennifer L Sullivan; Stephanie L Shimada; Kendra R Weaver; Jan A Lindsay; Mark S Bauer; Christopher J Miller
Journal:  Am Psychol       Date:  2021-12-23

8.  Ethical issues and practical barriers in internet-based suicide prevention research: a review and investigator survey.

Authors:  Eleanor Bailey; Charlotte Mühlmann; Simon Rice; Maja Nedeljkovic; Mario Alvarez-Jimenez; Lasse Sander; Alison L Calear; Philip J Batterham; Jo Robinson
Journal:  BMC Med Ethics       Date:  2020-05-13       Impact factor: 2.652

9.  A Systematic Review of the Evidence Supporting Mobile- and Internet-Based Psychological Interventions For Self-Harm.

Authors:  Usman Arshad; Jessica Gauntlett; Nusrat Husain; Nasim Chaudhry; Peter James Taylor
Journal:  Suicide Life Threat Behav       Date:  2019-08-26

10.  Medication for Opioid Use Disorder Service Provision and Telephone Counseling: A Concurrent Mixed-Methods Approach.

Authors:  Rosemarie Martin; Augustine W Kang; Audrey A DeBritz; Mary R Walton; Ariel Hoadley; Courtney DelaCuesta; Linda Hurley
Journal:  Int J Environ Res Public Health       Date:  2021-06-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.